Literature DB >> 31611221

Circulating regulatory T cells were absolutely decreased in dermatomyositis/polymyositis patients and restored by low-dose IL-2.

Sheng-Xiao Zhang1, Jia Wang1, He-Hua Sun1, Jia-Qian Zhang1, Guang-Ying Liu1, Jing Luo1, Pei-Feng He2, Xiao-Feng Li3.   

Abstract

Entities:  

Keywords:  dermatomyositis; polymyositis; treatment

Mesh：

Substances：

Year:  2019        PMID： 31611221     DOI： 10.1136/annrheumdis-2019-216246

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  9 in total

Review 1.  The Role of Regulatory T Cells in Pulmonary Arterial Hypertension.

Authors:  Wen Tian; Shirley Y Jiang; Xinguo Jiang; Rasa Tamosiuniene; Dongeon Kim; Torrey Guan; Siham Arsalane; Shravani Pasupneti; Norbert F Voelkel; Qizhi Tang; Mark R Nicolls
Journal:  Front Immunol       Date:  2021-08-19       Impact factor: 8.786

2.  Low-dose IL-2 therapy limits the reduction in absolute numbers of circulating regulatory T cells in rheumatoid arthritis.

Authors:  Sheng-Xiao Zhang; Jia Wang; Cai-Hong Wang; Rui-Huan Jia; Ming Yan; Fang-Yuan Hu; Guang-Ying Liu; Xue-Yu Liu; Jing Luo; Chong Gao; Xiao-Feng Li
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-04-28       Impact factor: 5.346

3.  Hypomyopathic Dermatomyositis with Refractory Dermatitis Treated by Low-dose IL-2.

Authors:  Miao Miao; Yuhui Li; Bo Huang; Jing He; Zhanguo Li
Journal:  Dermatol Ther (Heidelb)       Date:  2020-07-09

Review 4.  Low-Dose IL-2 Therapy in Autoimmune and Rheumatic Diseases.

Authors:  Hanna Graßhoff; Sara Comdühr; Luisa R Monne; Antje Müller; Peter Lamprecht; Gabriela Riemekasten; Jens Y Humrich
Journal:  Front Immunol       Date:  2021-04-01       Impact factor: 7.561

5.  The Gut Microbiota and Its Relevance to Peripheral Lymphocyte Subpopulations and Cytokines in Patients with Rheumatoid Arthritis.

Authors:  Yuan Li; Sheng-Xiao Zhang; Xu-Fang Yin; Ming-Xing Zhang; Jun Qiao; Xiao-Hong Xin; Min-Jing Chang; Chong Gao; Ya-Feng Li; Xiao-Feng Li
Journal:  J Immunol Res       Date:  2021-01-08       Impact factor: 4.818

Review 6.  Metabolism Characteristics of Th17 and Regulatory T Cells in Autoimmune Diseases.

Authors:  Yan Qin; Chong Gao; Jing Luo
Journal:  Front Immunol       Date:  2022-02-25       Impact factor: 7.561

7.  NLRP3 inflammasome up-regulates major histocompatibility complex class I expression and promotes inflammatory infiltration in polymyositis.

Authors:  Ping Xia; Yu-Quan Shao; Cong-Cong Yu; Yu Xie; Zhi-Jie Zhou
Journal:  BMC Immunol       Date:  2022-08-14       Impact factor: 3.594

8.  Differential distribution and prognostic value of CD4+ T cell subsets before and after radioactive iodine therapy in differentiated thyroid cancer with varied curative outcomes.

Authors:  Zhi-Yong Shi; Sheng-Xiao Zhang; Cai-Hong Li; Di Fan; Yan Xue; Zhe-Hao Cheng; Li-Xiang Wu; Ke-Yi Lu; Zhi-Fang Wu; Xiao-Feng Li; Hai-Yan Liu; Si-Jin Li
Journal:  Front Immunol       Date:  2022-08-26       Impact factor: 8.786

Review 9.  Targeting Regulatory T Cells for Therapy of Lupus Nephritis.

Authors:  Rajkumar Venkatadri; Vikram Sabapathy; Murat Dogan; Rahul Sharma
Journal:  Front Pharmacol       Date:  2022-01-06       Impact factor: 5.810
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.